LLY

1,010.95

-0.52%↓

JNJ

244.85

+0.48%↑

ABBV

226.37

-1.46%↓

NVS

162.78

-2.25%↓

MRK

120.9

-0.12%↓

LLY

1,010.95

-0.52%↓

JNJ

244.85

+0.48%↑

ABBV

226.37

-1.46%↓

NVS

162.78

-2.25%↓

MRK

120.9

-0.12%↓

LLY

1,010.95

-0.52%↓

JNJ

244.85

+0.48%↑

ABBV

226.37

-1.46%↓

NVS

162.78

-2.25%↓

MRK

120.9

-0.12%↓

LLY

1,010.95

-0.52%↓

JNJ

244.85

+0.48%↑

ABBV

226.37

-1.46%↓

NVS

162.78

-2.25%↓

MRK

120.9

-0.12%↓

LLY

1,010.95

-0.52%↓

JNJ

244.85

+0.48%↑

ABBV

226.37

-1.46%↓

NVS

162.78

-2.25%↓

MRK

120.9

-0.12%↓

Search

IQVIA Holdings Inc

Open

SectorHealthcare

166.43 0.62

Overview

Share price change

24h

Current

Min

164.88

Max

171.05

Key metrics

By Trading Economics

Income

1B

1.4B

Sales

264M

4.4B

P/E

Sector Avg

21.266

110.024

Profit margin

31.187

Employees

93,000

EBITDA

266M

1B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+35.75% upside

Dividends

By Dow Jones

Next Earnings

5 May 2026

Market Stats

By TradingEconomics

Market Cap

-11B

28B

Previous open

165.81

Previous close

166.43

News Sentiment

By Acuity

41%

59%

138 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

IQVIA Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Feb 2026, 22:31 UTC

Earnings

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 Feb 2026, 22:18 UTC

Earnings

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 Feb 2026, 22:11 UTC

Earnings

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 Feb 2026, 21:52 UTC

Earnings

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 Feb 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 Feb 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 Feb 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 Feb 2026, 23:34 UTC

Market Talk
Earnings

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 Feb 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 Feb 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 Feb 2026, 22:45 UTC

Earnings

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 Feb 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 Feb 2026, 22:37 UTC

Earnings

Nutrien 4Q EPS $1.18 >NTR.T

18 Feb 2026, 22:37 UTC

Earnings

Nutrien 4Q Sales $5.34B >NTR.T

18 Feb 2026, 22:35 UTC

Earnings

Pan American Silver 4Q EPS $1.07 >PAAS

18 Feb 2026, 22:35 UTC

Earnings

Pan American Silver 4Q Rev $1.18B >PAAS

18 Feb 2026, 22:30 UTC

Earnings

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 Feb 2026, 22:29 UTC

Earnings

Kinross Gold 4Q EPS 75c >K.T

18 Feb 2026, 22:22 UTC

Earnings

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 Feb 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 Feb 2026, 22:16 UTC

Earnings

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 Feb 2026, 22:05 UTC

Earnings

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 Feb 2026, 22:03 UTC

Earnings

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 Feb 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 Feb 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q Sales $929M >KALU

18 Feb 2026, 22:02 UTC

Earnings

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 Feb 2026, 22:00 UTC

Earnings

Kinross Gold 4Q Adj EPS 67c >KGC

18 Feb 2026, 22:00 UTC

Earnings

Kinross Gold 4Q Sales $2.02B >KGC

18 Feb 2026, 21:56 UTC

Earnings

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 Feb 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Peer Comparison

Price change

IQVIA Holdings Inc Forecast

Price Target

By TipRanks

35.75% upside

12 Months Forecast

Average 232.21 USD  35.75%

High 266 USD

Low 174 USD

Based on 16 Wall Street analysts offering 12 month price targets forIQVIA Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

12

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

150.68 / 153.45Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

138 / 351 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
help-icon Live chat